BlackRock MuniHoldings California Quality Fund Inc. (MUC) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

BlackRock MuniHoldings Ca... (MUC)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

10.62

0.13 (1.22%)

At close: Jan 15, 2025, 12:51 PM

undefined% (undefined)

Bid	10.61
Market Cap	999.76M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.43
PE Ratio (ttm)	24.69
Forward PE	n/a
Analyst	n/a

Ask	10.62
Volume	291,411
Avg. Volume (20D)	346,588
Open	10.56
Previous Close	10.49
Day's Range	10.56 - 10.64
52-Week Range	10.52 - 11.64
Beta	undefined

About MUC

BlackRock MuniHoldings California Quality Fund, Inc. is a closed ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in fixed income markets. It invests primarily in a portfolio of long-term investment-grade municipal obligations, the interest on which is exempt from Federal and California income taxes. BlackRock MuniHoldings California Quality Fund, Inc. was formed in 1997 and is ...

[Show more]

Industry Asset Management

Sector Financial Services

IPO Date Mar 2, 1998

Employees NaN

Stock Exchange NYSE

Ticker Symbol MUC

Website https://www.blackrock.com/investing/products/240270/blackrock-muniholdings-california-insured-fund-inc-usd-fund

News

2 days ago · businesswire.com

Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual property rights of the anti-tumo...